ARTICLE | Company News
DNX Biopharmaceuticals, XL-protein deal
August 3, 2015 7:00 AM UTC
The companies partnered to develop and commercialize long-acting biopharmaceutical products. XL-protein will contribute PASylation, its half-life extension technology, and undisclosed molecules that h...